1. Home
  2. GCTK vs ALBT Comparison

GCTK vs ALBT Comparison

Compare GCTK & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GlucoTrack Inc.

GCTK

GlucoTrack Inc.

HOLD

Current Price

$5.72

Market Cap

6.2M

Sector

Health Care

ML Signal

HOLD

Logo Avalon GloboCare Corp.

ALBT

Avalon GloboCare Corp.

HOLD

Current Price

$1.34

Market Cap

5.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GCTK
ALBT
Founded
2001
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2M
5.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GCTK
ALBT
Price
$5.72
$1.34
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
19.7K
56.6K
Earning Date
11-13-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,611,940.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.22
$1.21
52 Week High
$468.00
$11.66

Technical Indicators

Market Signals
Indicator
GCTK
ALBT
Relative Strength Index (RSI) 46.62 39.01
Support Level $5.53 $1.37
Resistance Level $6.71 $1.77
Average True Range (ATR) 0.46 0.20
MACD 0.04 0.03
Stochastic Oscillator 39.84 25.00

Price Performance

Historical Comparison
GCTK
ALBT

About GCTK GlucoTrack Inc.

GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.

About ALBT Avalon GloboCare Corp.

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

Share on Social Networks: